24 & 25 May 2012
5th International Symposium on Sentinel Node Biopsy in Head and Neck Cancer
Program
Program

Program 24 & 25 May 2012


Thursday 24 May 2012

08.30-09.15 REGISTRATION, COFFEE

09.15-09.30 Welcome

Introduction
09.30-09.50 History of sentinel node biopsy (Nieweg)
09.50-10.10 Sentinel node in non-head and neck (de Bree E)
10.10-10.30 The detection of occult cervical lymph node metastases (de Bree R)
10.30-10.50 Elective treatment of the neck (Leemans)
10.50-11.10 The introduction of sentinel node in head and neck cancer (Shoaib)

11.10-11.30 COFFEE

Clinical trials

11.30-12.00 SENT-trial (McGurk)

12.00-12.20 ACOSOG: long-term follow-up (Chepeha)
12.20-12.40 Canniesburn: long-term follow-up (Ross)
12.40-13.00 Switzerland: long-term follow-up (Stoeckli)

13.00-13.50 LUNCH

13.50-14.05 Sentinel lymph node biopsy in early tongue cancer with preoperative lymphoscintigraphy and intraoperative methylene blue injection - an attempt towards low cost-effective models to separate the wheat from chaff (Muthusami)
14.05-14.20 Sentinel node biopsy in head and neck cancer: a new perspetive (Chone)
14.20-14.35 A follow-up study on sentinel node biopsy negative patients - how is the outcome? (Sebessen)
14.35-14.50 Two years follow-up: sentinel lymph node biopsy in patients with cancer of the oral cavity (Sorensen)
14.50-15.05 The role of sentinel node technique in oral cancer (Ionna)

 

15.05-15.35 COFFEE

Pathology
15.35-15.55 Examination of the sentinel node (Bloemena)

15.55-16.10 Accurate histopathological determination of the status of the neck with serial cuts and immunohistochemical staining of the sentinel node (Cizmarevic)
16.10-16.25 Pathological and immunohistochemical predictors of regional lymph node metastasis in patients affected by oral squamous cell carcinoma (OSCC): a retrospective study on a series of cases treated with sentinel node biopsy (Poli)
16.25-16.40 Reliability of frozen section of sentinel node as a staging procedure in N0 neck in squamous cell carcinoma of the oral cavity (Bakholdt)
16.40-16.55 Validity of frozen section in sentinel lymph node biopsy for the staging in oral and oropharyngeal squamous cell carcinoma (Vorburger)
16.55-17.10 Histopathological mapping of metastatic tumor cells in sentinel lymph nodes of oral and oropharyngeal squamous cell carcinomas (Broglie)

 
17.10-17.20 Closing, photo

 

17.30 BOAT, DRINKS AND CONFERENCE DINNER



Friday 25 May 2012

 
08.00-08.45 REGISTRATION, COFFEE, PRESENTATION UPLOAD
 
Morbidity and costs
08.45-08.55 Morbidity after neck dissection (Chepeha)
08.55-09.10 Comparison of morbidity between sentinel node biopsy and elective neck dissection for treatment of the n0 neck in patients with oral squamous cell carcinoma (Stoeckli)
09.10-09.30 Costs (Van der Linden)
 
 
Miscellaneous
09.30-09.45 Head and neck cancer treatment with sentinel node biopsy without neck dissection (Chone)
09.45-10.00 Single fiber reflectance measurements of cervical lymph nodes for identifying metastasis from oral carcinoma (Witjes)
10.00-10.15 Sentinel node biopsy in cutaneous melanoma of the head and neck, based on early intradermal lymphoscintigraphic findings. A retrospective observational study on 74 patients (Tartaglione)
10.15-10.30 Distribution of platinum in sentinel node lymph nodes after preoperative intra-arterial cisplatin chemotherapy targeting primary tongue cancer (Sakashita)
10.30-10.45 SPECT-CT versus lymphoscintigraphy for sentinel lymph node mapping OSCC (Echevarria)

10.45-11.15 COFFEE

 
11.15-11.35 LarynxSN (Lawson)
11.35-11.50 Previously treated neck (Flach)
11.50-12.10 The prevalence of occult metastases in nonsentinel lymph nodes after step-serial sectioning and immunohistochemistry in cN0 oral squamous cell carcinoma (Bilde)
12.10-12.25 Detection of sentinel lymph nodes in cutaneous and intraoral head and neck squamous cell carcinoma with 99m-Tc-Tilmanocept: clinical experience at M.D. Anderson Cancer Center (Lai)

12.25-12.45 Joint (EANM / SENT) practice guidelines (Shoaib)
12.45-13.00 Limitations and improvements of the current sentinel node procedure (de Bree R)

13.00-14.00 LUNCH
 
Which technique is needed to identify the SN?   
14.00-14.40 Defining sentinel nodes on lymphoscintigraphy and SPECT/CT (Valdes Olmos) and
Panel discussion: What is de real sentinel node?

14.40-14.55 Visualisation of the sentinle node early stage oral cancer: limited value of late static lymphoscintigraphy (Flach)
14.55-15.10 PET-CT for sentinel node detection in head and neck cancer (Heuveling)
15.10-15.30 COFFEE

Fluorescence guided SN detection
15.30-15.45 Successful sentinel lymph node mapping with near-infrared fluorescence imaging in oral cavity or oropharyngeal cancer patients (Verbeek)
15.45-16.00 Feasibility study of ICG fluorescence navigated sentinel node biopsy in head and neck cancer (Hasegawa)
16.00-16.15 Clinical validation of a hybrid radioactive and fluorescent tracer for sentinel node procedures (Brouwer)
16.15-16.30 Hybrid radio- and fluorescence guided sentinel node biopsy in head and neck malignancies (Brouwer)
16.30-16.45 Nanocoll-IRDye800CW: a near-infrared fluorescent tracer with optimal retention in the sentinel lymph node (Heuveling)

16.45-16.50 Closing Conference

16.50-18.00 SENT MEETING


WelcomeVenueAboutFacultyProgramSymposium informationSENT meetingSponsorsContactLinks